ETON PHARMACEUTICALS INC (ETON)
US29772L1089 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 913.00K | -936.00K | -9.02M | -1.96M | -27.97M | |||
| Depreciation Amortization | 943.00K | 901.00K | 1.77M | 460.00K | 650.00K | |||
| Change In Working Capital | 836.00K | 3.60M | 7.72M | -6.21M | 1.01M | |||
| Interest Paid | 812.00K | 842.00K | 730.00K | 820.00K | 800.00K | |||
| Taxes Paid | 247.00K | 247.00K | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 3.20M | 3.25M | 4.35M | 2.98M | 3.96M | |||
| OPERATING CASH FLOW | 5.89M | 6.82M | 4.82M | -4.72M | -22.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.66M | -775.00K | -2.79M | -3.26M | -50.00K | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | 700.00K | N/A | |||
| INVESTING CASH FLOW | -2.66M | -775.00K | -2.79M | -2.56M | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.54M | -1.16M | -390.00K | -150.00K | 2.48M | |||
| Stock Issued/Repurchased | 75.00K | 198.00K | 250.00K | 540.00K | 29.15M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -1.28M | -957.00K | -130.00K | 390.00K | 31.63M | |||
| CHANGE IN CASH | 1.95M | 5.08M | 1.90M | -6.89M | 9.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 5.89M | 6.82M | 4.82M | -4.72M | -22.35M | |||
| Capital Expenditure | -2.66M | -775.00K | -2.79M | -3.26M | -50.00K | |||
| FREE CASH FLOW | 3.23M | 6.04M | 2.03M | -7.98M | -22.40M | |||
All data in USD